sglt2 inhibitors vs glp-1 GLP1 Receptor Agonists SGLT2-I in Preventing CKD in T2DM: An Interview – AJKD Blog Practice Nursing - GLP-1 receptor

Expertise and Experience: Our team stays abreast of the latest advancements in weight management therapies, providing evidence-based treatments

These are medications like Wegovy, Ozempic, and Mounjaro that mimic the GLP-1 hormone to help with weight loss and other medical issues

We offer extended hours seven days a week, including evenings and weekends

[DOI] [PubMed] [Google Scholar] 29.Ampudia-Blasco F.J., Calvo Gmez C., Cos Claramunt X., Garca Alegra J., Jdar Gimeno E., Mediavilla Bravo J.J., Mezquita Raya P., Navarro Prez J., Puig Domingo M

Wegovy and Ozempic, side-by-side A few caveats about the drugs follow, but keep in mind with the marketplace driving much of the thinking, and clinical experience evolving, there may be changes in store: Wegovy is FDA-approved for chronic weight loss management in adults 18 years of age or older with a BMI of 30 or BMI 27 and at least one medical condition related to obesity (e.g., diabetes, hypertension, etc.)